Contact Us
Back to Events
  • Published 20 Mar 2023

CatSci To Attend BioTrinity London 2023 

  • Events

CatSci Ltd, an award-winning innovation partner for medicines development, will be attending BioTrinity London 2023. Taking place on 25th – 26th April 2023, BioTrinity encourages growth and engagement in the life sciences industry.  

Our CEO, Dr Ross Burn, and our Head of Customer Acquisition, Jenn Clark, will be attending this established London conference. They are looking forward to engaging with the industry and exploring how CatSci can support your drug development needs.  

To book a meeting with Ross and Jenn, please get in touch here.  

Resources & Insights

Explore resources hub
  • 1 Apr 2026
  • Jean-Baptiste Vendeville
De-Risking Suzuki Development Through Integrated HTE and DoE
  • Analytical Chemistry
  • Chemical Development
  • Design of Experiments
  • High Throughput Experimentation
  • HTE
  • Scale-up
  • Whitepapers
2 MB
  • 17 Mar 2026
CatSci Annual Sustainability Report 2025
  • Sustainability
  • News
  • 9 Mar 2026
  • Rob Crook
High Throughput Experimentation: Fully Integrated or Modular System?
  • Chemical Development
  • High Throughput Experimentation
  • Process R&D
  • Thought Leaders
  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events